Sep 6, 2017 Cellectar Biosciences to Present at the 19th Annual Rodman and Renshaw Global Investment Conference Learn More
Aug 22, 2017 Cellectar Biosciences Announces Significant PDC Platform Advancement; Demonstrates Potential to Improve Therapeutic Window Learn More
Aug 14, 2017 Cellectar Biosciences Reports Second Quarter 2017 Financial and Corporate Performance Learn More
Aug 8, 2017 Cellectar Biosciences’ CLR 131 Achieves Overall Survival of Greater Than 22 Months in Advanced Multiple Myeloma Patients Learn More